Key result
Artificial intelligence technologies, particularly AlphaFold, are reshaping anesthesiology and perioperative medicine by accelerating drug discovery, optimizing treatment, and predicting complications.
Answers are grounded in this paper and cite their sources.
This review highlights the transformative potential of AI in anesthesiology, from accelerating drug discovery via protein structure prediction to optimizing personalized perioperative care.
The rapid development of artificial intelligence (AI) technology, in particular AlphaFold, has greatly improved protein structure prediction and design, reshaped protein biology and expanded research directions in anesthesiology and perioperative medicine. AI relies on deep learning to accurately model key proteins, such as G protein-coupled receptors, to aid drug development. In perioperative medicine, AI improves individualized treatment, patient safety and postoperative recovery through biomarker identification and anesthetic protocol optimization. In addition, AI accelerates anesthetic drug discovery, optimizes drug screening, toxicity prediction and clinical trials to improve the efficiency of research and development. Whilst data interpretation and diversity remain challenges, the continued advancement of AI in the fields of precision medicine and perioperative management will promote the development of individualized anesthesia and precision medicine.
No takes yet. Share an insight, caveat, or question.
Zhang et al. (2025) conducted a review in Anesthesia and perioperative medicine. Artificial intelligence was evaluated. Artificial intelligence technologies, particularly AlphaFold, are reshaping anesthesiology and perioperative medicine by accelerating drug discovery, optimizing treatment, and predicting complications.
Synapse has enriched 10 related papers. Consider them for comparative context: